Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37
Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Samarth Kulkarni
19 Oct 2026
Chief Executive Officer
Sell
47,837
$49.78
$2.38M
Simeon George
14 Oct 2026
Director
Sold after exercise
14,514
$49.63
$720.37K
Samarth Kulkarni
14 Oct 2026
Chief Executive Officer
Sell
4,098
$49.26
$201.87K
James R. Kasinger
14 Oct 2026
General Counsel and Secretary
Sell
1,040
$49.26
$51.23K
James R. Kasinger
6 Oct 2026
General Counsel and Secretary
Sold after exercise
1,990
$60.04
$119.48K

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 142,436
History held since 20 Oct 2016